Clinical Trial

A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this clinical evaluation is to collect patient outcome data and evaluate the efficacy, safety and tolerability of HealthTech DermaBind TL™ in patients with chronic non-healing wounds in patients with chronic non-healing ulcers.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-08; most recent amendment 2025-12-22.
Status change: Not Yet Recruiting → Recruiting 2025-12-11
Trial Details
NCT Number NCT07172893
Lead Sponsor HealthTech Wound Care
Conditions Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU)
Enrollment 150 participants
Start Date 2025-12-10
Primary Completion 2027-02-21 (estimated)
Study Completion 2027-05-21 (estimated)
Updated on ClinicalTrials.gov 2025-12-23